South and Central America Intradermal Injections Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Method (Normal Sized Needles, Short Needle, and Without Needle), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)
The intradermal injections market in South & Central America is expected to grow from US$ 213.89 million in 2021 to US$ 424.62 million by 2028. It is estimated to grow at a CAGR of 10.3% from 2021 to 2028.
Developed and Developing Countries Provide Significant Growth Opportunities to Market
Health systems in developing economies focus on introducing various advanced therapeutic, diagnostic, and aesthetic technologies into their service portfolios to be able to provide healthcare facilities with high efficiency. In developed countries, intradermal devices have received significant acceptance in vaccination and cosmetic procedures. In developing countries, although these devices are mainly used in vaccination, tuberculosis diagnosis, and aesthetic procedures, the market is currently in a nascent stage of development. Many developing countries are attractive destinations for medical tourism, especially for aesthetic procedures due to the lower costs of these procedures than developed countries. Health facilities, medical spas, and wellness centers in developing countries are increasingly offering a comprehensive range of inexpensive but high-quality medical-aesthetic procedures, which, eventually, triggers the demand for intradermal injections. The leading manufacturers of intradermal injections are developing ideal devices and collaborating with other players to improve the therapeutic efficacy of existing and new drugs. The rapid pace of urbanization, surging investments by healthcare providers in improving infrastructure, growing awareness among the population, and increasing availability of a range of advanced products and technologies are all contributing to the growth of this market.
The intradermal injections market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. In Brazil, the aging population is rising at a rapid pace, and the country faces regional and historical socioeconomic inequalities. It leads the South American pharmaceuticals market and medical device market, which can be mainly due to the huge population burden and a developed healthcare sector. With the high incidence of various communicable and noncommunicable diseases, the demand for intradermal injections has surged in the past few years. According to World Health Organization (WHO), the incidence rate of tuberculosis in Brazil was 45 per 100,000 population, with a detection rate of 78%, in 2020. Further, the growing cases of allergies, kidney diseases, cancer, etc., are likely to drive the adoption of medical devices, which will eventually drive the Brazil medical devices market during the forecast period.
South & Central America Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Intradermal Injections Market Segmentation
The South & Central America intradermal injections market is segmented on the basis of method, application, end user, and country. Based on method, the market is segmented into normal sized needle, short needle, and without needle. The normal sized needles segment registered the largest market share in 2021. The normal sized needles segment is further subsegmented into intradermal microinjections, microneedle arrays, and tattoo devices. The short needle segment is bifurcated into intradermal liquid jet injectors and ballistic intradermal injectors. In terms of application, the South & Central America intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. The tuberculin skin test segment held the largest market share in 2021. The South & Central America intradermal injections market, by end user, is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. The hospitals segment held the largest market share in 2021. Based on country, the market is segmented into Brazil, Argentina, and rest of South & Central America. Brazil dominated the market share in 2021.
BD; West Pharmaceutical Services, Inc; Terumo Corporation; Nanopass; PharmaJet; Idevax; Eunsung Global; Crossject; Cardinal Health Inc; and Hindustan Syringes and Medical Devices Ltd are the leading companies operating in intradermal injections market in the South & Central America region.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America intradermal injections market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America intradermal injections market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the intradermal injections market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook